HIGHLIGHTS
- who: Yu-Jin Lee and colleagues from the Department of Dermatology, Eunpyeong StMary`s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea have published the research: Interactions between Malassezia and New Therapeutic Agents in Atopic Dermatitis Affecting Skin Barrier and Inflammation in Recombinant Human Epidermis Model, in the Journal: (JOURNAL)
- what: The authors aimed to investigate how Malassezia Restricta (M. restricta) affects the skin barrier and inflammation in AD and interacts with the AD therapeutic agents ruxolitinib and anti-IL4Ru03b1. In the experiment, when anti-IL4Ru03b1 treatment was applied to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.